STOCK TITAN

Invitae to Present at the 41st Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Invitae (NYSE: NVTA), a leader in medical genetics, will have CEO Ken Knight present at the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023, at 12:00 p.m. Eastern. The presentation will be accessible through the company's investor section at ir.invitae.com. Invitae aims to provide comprehensive genetic information to improve healthcare, trusted by millions for personalized insights. A replay of the presentation will be available post-event.

Positive
  • None.
Negative
  • None.

SAN FRANCISCO, Jan. 4, 2023 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced that Ken Knight, president & chief executive officer, will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 12:00 p.m. Eastern / 9:00 a.m. Pacific.

The live audio webcast of the presentation may be accessed by visiting the investors section of the company website at ir.invitae.com. A replay of the webcast will be available shortly after the conclusion of the presentation.

About Invitae

Invitae (NYSE: NVTA) is a leading medical genetics company trusted by millions of patients and their providers to deliver timely genetic information simplified by digital technology. With accurate and actionable answers to strengthen medical decision-making, Invitae gives individuals and their families powerful, personalized insights that could improve and extend their lives. Invitae's genetics experts apply a rigorous approach to data and research, serving as the foundation of their mission to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people.

To learn more, visit invitae.com and follow for updates on Twitter, Instagram, Facebook and LinkedIn @Invitae.

Contacts for Invitae:

Investor Relations
Hoki Luk
ir@invitae.com

Public Relations
Amy Hadsock 
pr@invitae.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/invitae-to-present-at-the-41st-annual-jp-morgan-healthcare-conference-301712818.html

SOURCE Invitae Corporation

FAQ

When is Invitae's presentation at the J.P. Morgan Healthcare Conference?

Invitae's presentation will occur on January 11, 2023, at 12:00 p.m. Eastern time.

Who will represent Invitae at the J.P. Morgan Healthcare Conference?

CEO Ken Knight will represent Invitae at the conference.

How can I access the live presentation from Invitae?

The live webcast can be accessed at the investor section of Invitae's website: ir.invitae.com.

What is Invitae's mission in the healthcare industry?

Invitae's mission is to bring comprehensive genetic information into mainstream medical practice to improve healthcare.

What is the stock symbol for Invitae?

Invitae is listed under the stock symbol NVTA.

Invitae Corporation

NYSE:NVTA

NVTA Rankings

NVTA Latest News

NVTA Stock Data

5.59M
284.38M
1.51%
47.96%
23.65%
Diagnostics & Research
Healthcare
Link
United States
San Francisco